Immunity to Bacillus anthracis: Spore-Host Interactions
对炭疽杆菌的免疫:孢子-宿主相互作用
基本信息
- 批准号:7093090
- 负责人:
- 金额:$ 99.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
The overall objective of this program project is to provide sufficient understanding of the mechanisms of Bacillus anthracis spore-host interactions to facilitate the design and development of preventive, interventive and diagnostic procedures for the disease Anthrax. We will determine the detailed chemical structure of glycoproteins and other spore coat determinants and investigate the possibility that they can be used as new B. anthracis spore-specific targets for anthrax prevention and treatment. The detailed composition of the exosporium will be characterized by genetic and biochemical strategies. Individual mutations of all known, and to be discovered, exosporium components will be made. The structure of the carbohydrate components of the exosporium will be determined using a variety of genetic, chemical and spectroscopic methods. A mouse model will be used to identify the cellular pathways of spore entry and passage via the airways, gastrointestinal, cutaneous, and blood routes. Mice in which selected genes of the innate and adaptive immune system have been inactivated by gene-targeting will be used to define mechanisms of immunopathology and immune evasion of the ungerminated spores in the host. Wild type and mutant spores will be used to determine the role of these components in spore integrity, spore germination and survival in a mammalian host. We will isolate and characterize spore-receptors on host cells using spores, recombinant exosporium components and defined carbohydrates as ligands for these receptors.
In addition, this project will also involve the construction of carbohydrate-protein conjugates and neoglycoproteins designed on the basis of our structural studies. These constructs, in addition to cloned and expressed recombinant exosporium proteins, will be used to enhance immune responses to the glycoconjugates on the exosporium of B. anthracis, and assist in the development of novel vaccine or interventional strategies that will optimize specific protective primary and secondary immune responses, and may lead to new strategies for blockade of spore entry into the host. Our overall strategy differs from that currently in use which is designed to induce protective immunity to the toxins elaborated by the vegetative form of B. anthracis after spore invasion and germination in the host. We will be able to identify potential mechanisms to rapidly inactivate spores prior to establishment of infectious loci and vegetative cell outgrowth. Therapeutic drugs of this nature would be a major supplement to the current recommended antibiotic regimens or in the case of multidrug-resistant B. anthracis strains engineered to produce additional toxins for use as bioweapons.
描述(由申请人提供):
该计划项目的总体目标是充分了解炭疽芽孢杆菌孢子-宿主相互作用的机制,以促进炭疽病预防、干预和诊断程序的设计和开发。我们将确定糖蛋白和其他孢子衣决定簇的详细化学结构,并研究它们作为新的炭疽芽孢杆菌孢子特异性靶点用于炭疽预防和治疗的可能性。外孢子的详细组成将通过遗传和生化策略来表征。将产生所有已知的和待发现的孢子外成分的单独突变。外孢子的碳水化合物成分的结构将使用多种遗传、化学和光谱方法来确定。小鼠模型将用于识别孢子通过气道、胃肠道、皮肤和血液途径进入和通过的细胞途径。通过基因靶向使先天性和适应性免疫系统的选定基因失活的小鼠将被用来定义宿主中未发芽孢子的免疫病理学和免疫逃避机制。野生型和突变型孢子将用于确定这些成分在哺乳动物宿主中孢子完整性、孢子萌发和存活中的作用。我们将使用孢子、重组孢子外成分和确定的碳水化合物作为这些受体的配体来分离和表征宿主细胞上的孢子受体。
此外,该项目还将涉及根据我们的结构研究设计的碳水化合物-蛋白质缀合物和新糖蛋白的构建。除了克隆和表达的重组外孢子蛋白之外,这些构建体将用于增强对炭疽芽孢杆菌外孢子上的糖缀合物的免疫反应,并协助开发新的疫苗或干预策略,以优化特定的保护性初级和次级免疫反应,并可能导致阻断孢子进入宿主的新策略。我们的总体策略与目前使用的策略不同,目前使用的策略旨在诱导对炭疽芽孢杆菌孢子入侵和在宿主中萌发后的营养形式所产生的毒素的保护性免疫。我们将能够在感染位点建立和营养细胞生长之前确定快速灭活孢子的潜在机制。这种性质的治疗药物将是对目前推荐的抗生素治疗方案的主要补充,或者对于经改造可产生额外毒素以用作生物武器的多重耐药炭疽杆菌菌株的情况。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Franklin Kearney其他文献
John Franklin Kearney的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Franklin Kearney', 18)}}的其他基金
Development and maintenance of human glycan and phospholipid antibody repertoires
人聚糖和磷脂抗体库的开发和维护
- 批准号:
10396001 - 财政年份:2019
- 资助金额:
$ 99.96万 - 项目类别:
Development and maintenance of human glycan and phospholipid antibody repertoires
人聚糖和磷脂抗体库的开发和维护
- 批准号:
10592416 - 财政年份:2019
- 资助金额:
$ 99.96万 - 项目类别:
Antibody induction by Group B streptococcal vaccines for protection against fungal infections
B 组链球菌疫苗诱导抗体以预防真菌感染
- 批准号:
9090867 - 财政年份:2016
- 资助金额:
$ 99.96万 - 项目类别:
Effects of neonatal microbial exposure on anti-polysaccharide B cell development
新生儿微生物暴露对抗多糖 B 细胞发育的影响
- 批准号:
10218018 - 财政年份:2012
- 资助金额:
$ 99.96万 - 项目类别:
Effects of neonatal microbial exposure on anti-polysaccharide B cell development
新生儿微生物暴露对抗多糖 B 细胞发育的影响
- 批准号:
8433271 - 财政年份:2012
- 资助金额:
$ 99.96万 - 项目类别:
Effects of neonatal microbial exposure on anti-polysaccharide B cell development
新生儿微生物暴露对抗多糖 B 细胞发育的影响
- 批准号:
9755324 - 财政年份:2012
- 资助金额:
$ 99.96万 - 项目类别:
Effects of neonatal microbial exposure on anti-polysaccharide B cell development
新生儿微生物暴露对抗多糖 B 细胞发育的影响
- 批准号:
8298425 - 财政年份:2012
- 资助金额:
$ 99.96万 - 项目类别:
Effects of neonatal microbial exposure on anti-polysaccharide B cell development
新生儿微生物暴露对抗多糖 B 细胞发育的影响
- 批准号:
8609548 - 财政年份:2012
- 资助金额:
$ 99.96万 - 项目类别:
Effects of neonatal microbial exposure on anti-polysaccharide B cell development
新生儿微生物暴露对抗多糖 B 细胞发育的影响
- 批准号:
8797294 - 财政年份:2012
- 资助金额:
$ 99.96万 - 项目类别:
Effects of neonatal microbial exposure on anti-polysaccharide B cell development
新生儿微生物暴露对抗多糖 B 细胞发育的影响
- 批准号:
9011989 - 财政年份:2012
- 资助金额:
$ 99.96万 - 项目类别:
相似海外基金
Facility Management, Maintenance and Operations Core
设施管理、维护和运营核心
- 批准号:
10793949 - 财政年份:2023
- 资助金额:
$ 99.96万 - 项目类别:
Mechanisms of anthrax lethal toxin-induced mortality and the novel biological-based targeted therapies
炭疽致死毒素致死机制及新型生物靶向治疗
- 批准号:
10654406 - 财政年份:2023
- 资助金额:
$ 99.96万 - 项目类别:
Chemical Biology of Nitroxyl (HNO) in Bacillus Subtilis
枯草芽孢杆菌中硝酰基 (HNO) 的化学生物学
- 批准号:
10730746 - 财政年份:2023
- 资助金额:
$ 99.96万 - 项目类别:
How is climate change driving the re-emergence and evolution of anthrax
气候变化如何推动炭疽病的重新出现和进化
- 批准号:
2887605 - 财政年份:2023
- 资助金额:
$ 99.96万 - 项目类别:
Studentship
Development of a novel anthrax vaccine utilizing capsule biosynthesis protein CapA of Bacillus anthracis
利用炭疽杆菌荚膜生物合成蛋白CapA开发新型炭疽疫苗
- 批准号:
23K19460 - 财政年份:2023
- 资助金额:
$ 99.96万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Multiscale Modeling of B. Anthracis Surface Layer Assembly and Depolymerization by Nanobodies
纳米抗体对炭疽杆菌表面层组装和解聚的多尺度建模
- 批准号:
10432488 - 财政年份:2022
- 资助金额:
$ 99.96万 - 项目类别:
Metal requirement and mechanism of anthrax lethal factor and other zinc proteases
炭疽致死因子和其他锌蛋白酶的金属需求和机制
- 批准号:
RGPIN-2018-06496 - 财政年份:2022
- 资助金额:
$ 99.96万 - 项目类别:
Discovery Grants Program - Individual
Functional requirement of CMG2 for endothelial cell chemotaxis and resulting angiogenesis
CMG2 内皮细胞趋化性和由此产生的血管生成的功能要求
- 批准号:
10522258 - 财政年份:2022
- 资助金额:
$ 99.96万 - 项目类别:














{{item.name}}会员




